Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pathophysiological Role of Adrenergic Antibodies in Postural Tachycardia Syndrome (Aims #1&2)

NCT02673996 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT02673996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02673996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pathophysiological Role of Adrenergic Antibodies in Postural Tachycardia Syndrome (Aims #1&2)
Lead sponsor
University of Calgary
Phase
Observational
Overall status
Recruiting
Start date
January 31, 2016
Completion date
December 31, 2030
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postural tachycardia syndrome